The First Global Expo for Longevity & Medical Innovation
Medical innovation congresses exist - but none offer a true platform where innovators, investors, and patients meet under one roof. XMed is poised to offer this platform to explore and meet
Highly differentiated genomics analysis is becoming standard. Artificial intelligence is accelerating drug discovery, patient stratification, and treatment development at unprecedented speed — delivering therapies that are more precise, faster to market, and increasingly curative.
Shanghai stands at the epicenter of biotech innovation — with active funding, fast-track pathways for cell therapy, and longevity research, and novel nimble pathways to translate R&D findings into real patient applications.
Recent developments show an possible advantage and acceleration of novel treatment approaches in China — with innovation hubs, streamlined regulation, and strong public-private partnerships.
Potentially lower treatment costs while striving for superior quality. New GMP facilities, CROs, and gene therapy manufacturing sites opening..
Shanghai Biotech Innovation Park and Zhangjiang Science City — aiming to rival Boston, Singapore, and Zurich as a top-tier global biotech hub with continued funding and fast-track pathways for development of advanced therapies.
Medicine is evolving. The focus is shifting from treating disease after onset to achieving longevity — enhancing energy, lifespan, and quality of life. With novel peptide approaches and other, a new era has begun where prevention leads over reactive treatment.
CAR-T, stem cell therapies, and regenerative cellular approaches for cancers, immune disorders, and chronic disease.
Artificial intelligence accelerating drug discovery, patient stratification, and highly differentiated genomics analysis at unprecedented speed.
Peptide therapies, metabolic optimisation, and prevention-first protocols extending healthspan — energy, lifespan, and quality of life beyond the current state of the art.
Connecting patients and providers with cutting edge approaches to provide wider access to novel therapies.
Active funding with fast-track approvals, strong public-private partnerships, and a curated global investor and co-development community.
XMed offers an unmatched convergence of research, innovation, capital, and clinical application — all in Shanghai's world-leading biotech corridor. Join the shift from treatment to cure.
Built by world-class experts bridging cutting-edge science with commercial reality — and international exhibition experience across Asia.
Decades of expertise in biotech strategy, R&D translation, and cross-border innovation. Dr. Sersch bridges cutting-edge science with commercial reality, with a strong network across US and Asian biotech hubs.
30+ years of experience in international exhibitions. Bjoern has built and scaled major trade shows across Asia, connecting investors, innovators, and industries. His track record ensures a world-class expo experience.
Together, they are building the first global expo for medical innovation, longevity, and patient-centric research — hosted in Shanghai, open to the world. Join us. Be a part of the shift from treatment to prevention with the ultimate goal of quality of life at all ages.
SNIEC Hall E5 · Shanghai · March 13–15, 2027
Thank you for registering your interest in XMed Expo & Conference 2027. Our team will be in touch shortly with further details.
March 13–15, 2027 · SNIEC Hall E5 · Shanghai